Who are we ?

NeurATRIS, translational research infrastructure for innovative neuroscience therapies.


An infrastructure unique in Europe

NeurATRIS, coordinated by CEA, is a national research infrastructure to accelerate the translation of discoveries in basic research into medical innovations for the treatment of neurodegenerative and neurodevelopmental diseases.

Created in 2012 following the « Investissements d’Avenir » call for projects "Biology and Health Infrastructure", its objective is to offer a continuum of translational expertises ranging from in vitro cellular models to phase II clinical trials on patients suffering from major brain diseases, such as Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), Multiple Sclerosis (MS) or certain brain development disorders.

Organized as a one-stop network, NeurATRIS is designed to co-ordinate research activities and technological development serving the scientific and industrial communities. It simplifies the access and the use of high level platforms (see « Platforms of NeurATRIS ») and facilitates the participation of French players in European initiatives. It also improve the attractiveness and visibility of France in the field of translational neuroscience research.


An infrastructure based on scientific excellence in neuroscience and neurology

NeurATRIS brings together 7 hospitals and public research institutes whose expertise and skills in neuroimaging, pharmacology and biotherapies are complementary and internationally recognized: 


This synergy fully meets the needs of discovery, characterisation and validation of therapeutic targets, as well as the identification of new biomarkers. It also enables the establishment of collaborations with academic and private partners by providing state-of-the-art services based on a range of technological, scientific, methodological and strategic expertise that is essential in the value chain of translational neuroscience research activities.


INBS: NeurATRIS is one of the 27 national infrastructures in biology and health (INBS) listed in the roadmap of the French Ministry of Higher Education, Research and Space (MESR), updated in 2021.


Established in 2011 as part of the Future Investment Programme, the role of INBS has grown steadily over the years, and they have now become key strategic assets for French life sciences research. Serving research excellence, they provide cutting-edge services to researchers and industry, support and train scientific communities, and foster technological innovation. Some of them, including NeurATRIS, also benefit from recognition at the European level.

INBS Club: NeurATRIS is a member of the INBS Club, which brings together the leading national infrastructures in the life sciences. Established in 2021, the Club provides a dedicated forum for exchange and collaboration, enabling its members to share experience, develop joint initiatives, and strengthen the visibility of national infrastructures. Through thematic working groups and regular meetings, the Club contributes to advancing practices and to giving the infrastructures a collective voice among research stakeholders and public authorities.


EATRIS: NeurATRIS is the French component of the European infrastructure in translational research EATRIS-ERIC; it is also the only EATRIS infrastructure proposing a structured offer specialized in neuroscience and neurology, allowing France to position itself as an important player in this field at international and European levels.

To learn more about Eatris : https://eatris.eu/


NeurATRIS received €31.3 million in funding over a 13-year period, as part of the 2012 Future Investment Programme (PIA), covering the period from 2012 to 2024.

For more information about the PIA: https://www.info.gouv.fr/actualite/le-programme-d-investissements-d-avenir